Mandate

Vinge advises Utbildning och Vård Koncern Sverige AB in connection with the sale of Baggium Vård & Behandling Aktiebolag

June 13, 2011

Vinge has advised Utbildning och Vård Koncern Sverige AB in connection with the sale of Baggium Vård & Behandling Aktiebolag. Baggium AB has disposed of Baggium Vård & Behandling Aktiebolag which owns and operates 14 units to the Humana group. The operations have an approximate turnover of SEK 130 million with 125 employees and 140 students. Humana’s competence and experience in providing support for, and service to, children and young persons with special needs will provide the right conditions to develop the operations.
The Vinge team that advised Utbildning och Vård Koncern Sverige AB consisted of Petter Kjöllerström (project manager), Fabian Ekeblad (responsible partner), and associates Louise Markgren, Viveka Linander, Anders Frick, Linnéa Blommé, Julia Nordgren and project assistant Annika Johnson

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026